Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Julai 2026, 17:31:49
Self-monitoring of blood glucose in diabetes mellitus
Self-monitoring of blood glucose (SMBG) is the regular measurement of blood glucose levels by patients using a portable glucometer. It is an important component of diabetes management that enables patients and healthcare providers to evaluate glycaemic control, assess the effectiveness of treatment, detect hypo- and hyperglycaemia early, and make informed decisions regarding medication, diet, and physical activity.
SMBG is particularly valuable in patients receiving insulin therapy or medications that increase the risk of hypoglycaemia. When performed correctly and interpreted appropriately, it contributes to improved glycaemic control, reduces diabetes-related complications, and promotes patient self-management.
Indications
SMBG is recommended in the following situations:
Patients receiving insulin therapy
Patients taking sulphonylureas or other medicines that may cause hypoglycaemia
During pregnancy and pre-pregnancy planning
During acute illness or infection
Following changes in diabetes treatment
During major lifestyle modifications affecting glucose control
When HbA1c measurements are unreliable (e.g., haemoglobinopathies, haemolytic anaemia)
Patients with recurrent hypoglycaemia
Patients with poor glycaemic control requiring treatment adjustment
Objectives
The objectives of SMBG are to:
Assess daily glycaemic patterns
Detect asymptomatic hypoglycaemia
Detect persistent hyperglycaemia
Guide adjustment of insulin and oral hypoglycaemic therapy
Assess the effects of meals, exercise, illness, and medications
Improve patient understanding of diabetes
Reduce the risk of acute and chronic diabetes complications
Recommended frequency of monitoring
The frequency of SMBG should be individualized according to the patient's treatment regimen and clinical status.
Patients receiving intensive insulin therapy
Monitoring is generally recommended:
Before each meal
At bedtime
Occasionally 2 hours after meals
Before exercise
After exercise if hypoglycaemia is suspected
Whenever symptoms of hypo- or hyperglycaemia occur
Before driving or operating heavy machinery if appropriate
This usually results in 3–7 measurements daily.
Patients receiving basal insulin
Monitoring is commonly recommended:
Daily fasting blood glucose
Additional testing when insulin doses are adjusted
During illness or symptomatic episodes
Patients receiving oral hypoglycaemic agents
Routine SMBG may not be necessary for all patients.
Monitoring is useful:
During treatment initiation
During medication adjustment
When using sulphonylureas
During illness
When glycaemic control deteriorates
Pregnancy
Women with diabetes during pregnancy generally require more frequent monitoring, including:
Fasting blood glucose
Before meals
One or two hours after meals
At bedtime
The frequency should be individualized according to obstetric and diabetic management.
Target blood glucose levels
General glycaemic targets for most adults are:
Measurement | Target |
Fasting blood glucose | 4–6 mmol/L |
Two-hour postprandial glucose | 6–8 mmol/L |
HbA1c | ≤7% (6.5–7.5%) |
Targets should be individualized for elderly patients, pregnant women, children, and those at high risk of hypoglycaemia.
Procedure
Patients should be educated on the correct technique for blood glucose testing.
The procedure includes:
Wash and dry hands thoroughly.
Insert a test strip into the glucometer.
Use a sterile lancet to obtain a capillary blood sample from the side of the fingertip.
Apply the blood sample to the test strip according to the manufacturer's instructions.
Read and record the blood glucose result.
Dispose of the lancet safely in an approved sharps container.
Patients should avoid squeezing the fingertip excessively, as this may alter the result.
Interpretation of results
SMBG results should always be interpreted together with:
Meal timing
Medication use
Physical activity
Symptoms
Recent illness
Stress
Alcohol intake
Persistent abnormal readings should prompt medical review and treatment adjustment.
Causes of high blood glucose readings
Common causes include:
Missed medication or insulin doses
Excess carbohydrate intake
Acute illness
Infection
Psychological stress
Reduced physical activity
Inadequate insulin dosing
Corticosteroid therapy
Causes of low blood glucose readings
Common causes include:
Excess insulin
Excess sulphonylurea dose
Delayed or missed meals
Increased physical activity
Alcohol intake
Vomiting or diarrhoea
Renal impairment
Recording blood glucose
Patients should maintain a blood glucose diary documenting:
Date
Time of measurement
Blood glucose result
Meals
Medication doses
Physical activity
Symptoms of hypo- or hyperglycaemia
Any unusual events
These records assist healthcare providers in optimizing treatment.
Advantages
SMBG offers several benefits, including:
Early detection of abnormal glucose levels
Improved glycaemic control
Better treatment adjustment
Increased patient engagement
Reduced risk of severe hypoglycaemia
Prevention of diabetes complications
Improved quality of life
Limitations
Potential limitations include:
Cost of test strips and lancets
Pain associated with finger-prick testing
Inaccurate technique leading to erroneous results
Poor adherence
Limited usefulness in patients with stable diabetes managed by diet alone
Anxiety related to frequent testing in some patients
Patient education
Patients should receive education regarding:
Proper glucometer use
Correct hand hygiene before testing
Safe disposal of lancets
Appropriate testing frequency
Interpretation of results
Recognition of hypo- and hyperglycaemia
Importance of maintaining a glucose record
Situations requiring medical attention
When to seek medical attention
Patients should seek medical review if they experience:
Persistent fasting blood glucose above target despite treatment
Recurrent hypoglycaemia
Severe hypoglycaemia requiring assistance
Persistent blood glucose greater than 15 mmol/L
Symptoms of diabetic ketoacidosis or hyperosmolar hyperglycaemic state
Repeated unexplained fluctuations in blood glucose
Clinical pearls
SMBG complements but does not replace HbA1c measurement.
Patients using insulin generally require more frequent monitoring than those managed with oral medications alone.
SMBG results should always be interpreted in the context of meals, medications, physical activity, and clinical symptoms.
Education on proper glucometer technique is essential to obtain accurate and reliable results.
Maintaining a blood glucose diary improves treatment decisions and supports long-term diabetes management.
Imeandikwa:
28 Julai 2026, 10:38:57
Rejea za mada hii:
Ministry of Health, United Republic of Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 2023 ed. Dodoma: Ministry of Health; 2021.
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S19–S40. doi:10.2337/dc23-S002.
American Diabetes Association. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S41–S48.
American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S140–S157.
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–2786.
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.
Disclaimer: The information provided on this platform is for educational and informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Clinical recommendations are primarily based on the Tanzania Standard Treatment Guidelines and National Essential Medicines List (STG & NEMLIT), Seventh Edition, 2023, unless otherwise stated.
